Abukhder Munir, Sahovaler Axel, Vrakas Panagiotis, McGurk Mark, Thavaraj Selvam, Schilling Clare
University College London Hospital, London, United Kingdom.
Head and Neck Academic Centre, Division of Surgery and Interventional Science, University College London, London, United Kingdom.
JAMA Otolaryngol Head Neck Surg. 2024 Oct 10;150(11):1021-8. doi: 10.1001/jamaoto.2024.3094.
Frozen section (FS) analysis of sentinel nodes offers potential on-table diagnosis and treatment for occult metastasis in oral squamous cell cancer. Systematic analysis of FS during sentinel node biopsy has not been illuminated in the literature.
To systematically review pooled data from studies using FS analysis in evaluating sentinel nodes in patients with cT1-T2 N0 oral squamous cell cancer.
An academic librarian led the search of CENTRAL, CINAHL, Cochrane Database of Systematic Reviews, Embase, and MEDLINE for studies published in English between January 2000 and January 2023.
Two authors independently screened cohort studies, case series, and randomized clinical trials, in which FS analysis was used to evaluate sentinel nodes in patients with cT1-T2 N0 oral squamous cell cancer.
Data were extracted by 2 reviewers. Reporting quality was estimated using the Diagnostic Precision Study Quality Assessment Tool. Data analysis was performed between April and July 2023, and the meta-analysis was completed using the bivariate random-effects model.
The primary outcome was the pooled sensitivity of FS sentinel node analysis. Secondary outcomes included evaluation of the FS technique, rate of occult metastasis, false-negative rate, and survival.
Seventeen articles with 878 patients met the eligibility criteria. Although protocols varied, confirmatory serial step sectioning was performed in all studies. Occult metastasis was found in 263 of 878 patients (30%), and FS analysis identified 173 cases (65.8%). Following serial sectioning, an additional 90 positive results were identified, leading to 47 patients undergoing staged completion neck dissection. The pooled sensitivity of FS was 0.71 (95% CI, 0.60-0.80), the diagnostic odds ratio was 110, and the false-negative rate was 34.2%. The Cochrane Q value was 15.62 (df = 16; P = .48) and τ2 = 0.36.
In this systematic review and meta-analysis, evaluated studies showed various techniques, in which pooled sensitivity reached 0.71, providing a benchmark for comparison to other 1-stop approaches. Due to the high false-negative rate of approximately one-third of patients, intraoperative FS must always be supplemented by serial sectioning. On-table diagnosis remains a key objective for sentinel node biopsy, and FS detection may be improved by standardizing protocols.
前哨淋巴结的冰冻切片(FS)分析可为口腔鳞状细胞癌隐匿性转移提供术中诊断和治疗的可能。前哨淋巴结活检过程中FS的系统分析在文献中尚未阐明。
系统回顾使用FS分析评估cT1-T2 N0期口腔鳞状细胞癌患者前哨淋巴结的研究汇总数据。
由一名学术图书馆员在CENTRAL、CINAHL、Cochrane系统评价数据库、Embase和MEDLINE中检索2000年1月至2023年1月期间以英文发表的研究。
两名作者独立筛选队列研究、病例系列和随机临床试验,其中FS分析用于评估cT1-T2 N0期口腔鳞状细胞癌患者的前哨淋巴结。
由2名审阅者提取数据。使用诊断准确性研究质量评估工具评估报告质量。2023年4月至7月进行数据分析,使用双变量随机效应模型完成荟萃分析。
主要结局是FS前哨淋巴结分析的汇总敏感性。次要结局包括对FS技术的评估、隐匿性转移率、假阴性率和生存率。
17篇文章共878例患者符合纳入标准。尽管方案各不相同,但所有研究均进行了验证性连续切片。878例患者中有263例(30%)发现隐匿性转移,FS分析识别出173例(65.8%)。连续切片后,又发现90例阳性结果,导致47例患者接受分期根治性颈清扫术。FS的汇总敏感性为0.71(95%CI,0.60-0.80),诊断比值比为110,假阴性率为34.2%。Cochrane Q值为15.62(自由度=16;P=0.48),τ2=0.36。
在本系统评价和荟萃分析中,评估的研究显示了各种技术,其中汇总敏感性达到0.71,为与其他一站式方法进行比较提供了一个基准。由于约三分之一患者的假阴性率较高,术中FS必须始终辅以连续切片。术中诊断仍然是前哨淋巴结活检的关键目标,标准化方案可能会提高FS检测率。